Turku University Hospital
Turku, Finland
NCT Number: NCT06679127
The aim of this clinical pilot study is to evaluate the validity, acceptability and usability of the newborn bed monitoring device among newborns, parents and healthcare professionals in hospital environment. The specific aims for the study are to:
1. validate the following infant parameters collected with the bed monitoring device: heart rate, breathing rate, movements. 2. evaluate the feasibility on detecting awake, REM and non-REM sleep stages 3. collect data on environmental factors from the infant sleep environment 4. explore how parents and healthcare professionals perceive the acceptability and usability of the bed monitoring device 5. describe the key requirements for the bed monitoring device to be implemented in the newborn care path
The participating newborns will be sleeping on the bed monitoring device for two hours and the measurements of the device will be compared with the reference device (golden standard). The acceptability and usability will be assessed by parents and healthcare professionals by fulfilling a questionnaire and participating in interviews.
Looking for future studies?
Notify MeAll sexes
Observational
Turku, Finland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for newborns:
Inclusion criteria
for parents:
Inclusion criteria
for healthcare professionals:
Time frame: Two hours from the beginning of the data collection
Anna Axelin
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07578233
Magnetic Resonance Imaging, Multiparametric
Cairo, Egypt
View Trial DetailsNCT06392698
Fear Anxiety, Validation
Herning, Denmark
View Trial DetailsNCT06805435
Blood Pressure, Device
Moreno Valley, California, United States
View Trial DetailsNCT05678920
Validation
Samsun, Turkey (Türkiye)
View Trial Details